openPR Logo
Press release

Technology Spending on Revenue Cycle Management Market is set to Garner Staggering Revenues by 2024

08-30-2017 03:05 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Technology Spending on Revenue Cycle Management Market is set

McKesson Corporation, Allscripts, Cerner Corporation, and Optum Health, Inc. were the leading players in the global market for technology spending on revenue cycle management in 2015. These key companies show the common strengths in having built strong distribution channels and effective long-term partnerships.

Read More Information Regarding Technology Spending on Revenue Cycle Management Market: http://www.transparencymarketresearch.com/technology-spending-revenue-cycle-management.html#tab-1

According to a research report released by Transparency Market Research, technology spending on revenue cycle management is expected to experience a buildup in competitive rivalries over time, owing to the entry of more players into the global market. The market is in a very expansive stage, which coupled with the recent positive changes in the regulatory scenario, have created a very advantageous position for a lot of new entrants. The global market for technology spending on revenue cycle management is expected to reach US$51.56 bn by 2024. It is expected to expand at an optimistic CAGR of 6.9% within a forecast period from 2016 to 2024, and was calculated at US$28.50 bn at the end of 2015.

Staggering Advantages Pull Healthcare Organizations towards Revenue Cycle Management Solutions

“Of the many plus points that go with a standard revenue cycle management solution, the leading factor that a lot of healthcare organizations are looking for is better revenue generation. Claims get processed much faster under revenue cycle management solutions, along with a speedy denial management, thereby helping an organization generate a higher resolution rate. Thus, time saved becomes money earned and that is what is driving the global market for technology spending on revenue cycle management currently,” states a TMR analyst.

Another driver for the global technology spending on revenue cycle management market is the greater efficiency achieved in carrying out medical practice. When a revenue cycle management solution is implemented, a hospital can shift their focus off patient billing and paperwork, thereby becoming a more patient-centric organization and thus improving patient recovery outcomes. The implementation of a revenue cycle management solution can also allow a healthcare organization to safely adhere to the current state of regulatory structures. Since these processes are needed to by in sync with any changes in regulations, the organization can rest assured that all rules and requirements are satisfied through the implementation of RCM solutions.

Complexity of RCM Solutions may Stifle Administrative Processes even Further

One of the core restraints acting on the global market for technology spending on revenue cycle management is the complexity of these solutions. A lot of claims submission processes involve tedious iterations of rework. Combined with the long and erroneous processes of data collection and other manual processes, the incorporation of a revenue cycle management solution into this will add to the errors that accumulate. On an average, close to 30% of all physician claims are erroneous and 15% of the claims may even get lost in the processes. The addition of a revenue cycle management solution to such an inaccurate data generation stream can only cause inaccurate results to be posted, thereby restricting the overall advantages that these solutions can bring to the table.

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17597

“Players in the global market for technology spending on revenue cycle management can look forward to operating in emerging economies of the Asia Pacific over the coming years. The rate at which the healthcare industry is evolving can bring about optimistic strategies in the implementation of revenue cycle management solutions in these countries,” adds the analyst.

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Technology Spending on Revenue Cycle Management Market is set to Garner Staggering Revenues by 2024 here

News-ID: 691799 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Cycle

Full Life Cycle API Management Market to Set New Growth Cycle | Mulesoft, Google …
Global Full Life Cycle API Management Market Report 2020, Covid 19 Outbreak Impact research report added by Report Ocean, predicts the industry’s performance for the upcoming years to help stakeholders in making the right decisions that can potentially garner strong returns. Further, the document provides comprehensive analysis of the key industry trends as well as the opportunities that will ensure an upward growth trajectory in the coming years. It also
Submarine AIP System Market Segmented By product type Closed Cycle Diesel Engin …
This Fact.MR Report examines, global submarine AIP system market for the forecast period 2017–2026. The prime purpose of the report is to find opportunities and trends in the market and provide insights pertaining to segments of the global submarine AIP system market. To understand the opportunities and trends in this market, the report is categorically divided into three sections namely on the basis of product type, fit type, and region. The
In-vitro fertilization (IVF) Market By Types of cycle (Fresh Cycle (Non-Donor), …
Global In-vitro fertilization (IVF) Market was valued at USD 507.98 Million in the year 2017. Global In-vitro fertilization (IVF) Market is further estimated to grow at a CAGR of 10.41 % from 2018 to reach USD 920 Million by the year 2023. North America region holds the highest market share in 2017 and Europe is considered as the fastest growing market in the forecasted period. At country level, developed markets
Technology Spending on Revenue Cycle Management Market - APAC Grows Stronger in …
McKesson Corporation, Allscripts, Cerner Corporation, and Optum Health, Inc. were the leading players in the global market for technology spending on revenue cycle management in 2015. These key companies show the common strengths in having built strong distribution channels and effective long-term partnerships. Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17597 According to a research report released by Transparency Market Research, technology spending on revenue cycle management is expected to experience a buildup in competitive rivalries
Technology Spending on Revenue Cycle Management Market - APAC Grows Stronger in …
Global Technology Spending on Revenue Cycle Management: Snapshot The global technology spending on revenue cycle management is primarily being driven by the wide array of advantages that their implementation can offer, such as increase in revenue generation, better efficiency in healthcare practices, easier compliance with industry norms and regulations, and greater accuracy and easier access to healthcare IT systems. However, its market is currently being restricted by a host of issues,
Aeroderivative Gas Turbine Market By Technology (Open Cycle, Combined Cycle), In …
Combined cycle aeroderivative gas turbine market for 2015 was over 5 GW and looks set to see handsome growth. Rising acceptance across cogeneration electricity generating stations owing to its fast start and cycling capabilities will complement the business outlook. Aeroderivative Gas Turbine Market size will exceed 21 GW by 2024, as reported in the latest study by Global Market Insights, Inc. Rising cogeneration technology adoption to meet the growing electricity